| Methods |
Randomised clinical trial.
Generation of allocation sequence: no
information.
Allocation concealment: no information.
Blinding: no blinding.
Loss to follow‐up: none.
Jadad
score=2. |
| Participants |
Ethnic: Chinese.
122 patients, no data on sex and age.
Setting: unstated.
Inclusion criteria: chronic hepatitis B with
HBsAg positive for more than six months, diagnosed according to the criteria
of the National Conference on Viral Hepatitis (CMA 1990).
Exclusion
criteria: unstated. |
| Interventions |
Experimental:
Phyllanthus amarus (single herb) syrup, 20 ml (5 g)
orally, t.i.d, for 30 days.
Control:
Vitamins, plus
hypoxanthosine and alcamin, for 30 days; but no data on dosage and
route. |
| Outcomes |
HBV markers, liver function and adverse effects.
Follow‐up: six
months. |
| Notes |
Sent letter (7/6) |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Allocation concealment? |
Unclear risk |
B ‐ Unclear |
